[HTML][HTML] CYP2D6 overview: allele and phenotype frequencies

M Kane - Medical Genetics Summaries [Internet], 2021 - ncbi.nlm.nih.gov
Genetic variation has a significant impact on an individual's metabolism and response to a
wide range of medications. The cytochrome P450 family of enzymes are key determinants in …

[HTML][HTML] Frequency of CYP2D6 alleles including structural variants in the United States

AL Del Tredici, A Malhotra, M Dedek, F Espin… - Frontiers in …, 2018 - frontiersin.org
The CYP2D6 gene encodes an enzyme important in the metabolism of many commonly
used medications. Variation in CYP2D6 is associated with inter-individual differences in …

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

M Ingelman-Sundberg - The pharmacogenomics journal, 2005 - nature.com
CYP2D6 is of great importance for the metabolism of clinically used drugs and about 20–
25% of those are metabolised by this enzyme. In addition, the enzyme utilises …

Prediction of CYP2D6 phenotype from genotype across world populations

A Gaedigk, K Sangkuhl, M Whirl-Carrillo, T Klein… - Genetics in …, 2017 - nature.com
Purpose: Owing to its highly polymorphic nature and major contribution to the metabolism
and bioactivation of numerous clinically used drugs, CYP2D6 is one of the most extensively …

Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization

J Kevin Hicks, JJ Swen, A Gaedigk - Current drug metabolism, 2014 - ingentaconnect.com
The cytochrome P450 2D6 (CYP2D6) enzyme contributes to the metabolism and/or
bioactivation of approximately 25% of clinically used drugs. The CYP2D6 gene locus is …

How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments

M De Gregori, M Allegri, S De Gregori… - Current drug …, 2010 - ingentaconnect.com
Cytochromes P450 are members of a superfamily of hemoproteins that catalyze a variety of
oxidative reactions in the metabolism of endogenous and exogenous hydrophobic …

Pharmacogenetics: the molecular genetics of CYP2D6 dependent drug metabolism.

JY Wong, ES Seah, EJ Lee - Annals of the Academy of Medicine …, 2000 - europepmc.org
Methods This article reviews the information derived from various studies over the past
decade and explains the molecular basis of functional differences in CYP2D6 variants …

Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance

LK Teh, L Bertilsson - Drug metabolism and pharmacokinetics, 2012 - jstage.jst.go.jp
CYP2D6 has received intense attention since the beginning of the pharmacogenetic era in
the 1970s. This is because of its involvement in the metabolism of more than 25% of the …

A silent mutation (2939G> A, exon 6; CYP2D6* 59) leading to impaired expression and function of CYP2D6

C Toscano, S Raimundo, K Klein… - Pharmacogenetics …, 2006 - journals.lww.com
We analyzed CYP2D6 in two individuals characterized by impaired sparteine oxidation
(intermediate metabolizer phenotype) and genotype 2D6* 2/* 4 (1661G> C; 2850C> T; …

CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure

J Sistonen, A Sajantila, O Lao, J Corander… - Pharmacogenetics …, 2007 - journals.lww.com
Methods A total of 1060 individuals belonging to 52 worldwide-distributed populations were
genotyped at 12 highly informative variable sites, as well as for gene deletion and …